Randomized controlled clinical study to evaluate efficacy of bruhatlashunpinda and rasnasaptak kwatha in the management of manyastambha with special reference to cervical spondylosis.

Dr Prachi Patwari0 个研究点目标入组 0 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Well diagnosed patients of manyastambha (Cervical spondylosis).
•2.Subjects having neck pain with or without radicular symptoms paresthesia since more than two months.
•3.Cervical spondylitis confirmed by radiological assessment (X ray cervical vertebrae AP and lateral view.
•4.Subjects were willing to give informed consent and ready to comply with the protocol.
•5.Subjects who are ready to provide regular follow ups till completion of the study.

•1.Known cases of trauma of neck, local wound and infection over neck, cervical rib syndrome, any spinal cord disorders other than cervical spondylosis & myelopathy.
•2.Known cases of shoulder and elbow musculoskeletal problems, fracture of spine and upper limb.
•3.Known cases of inflammatory arthritis.
•4.Subjects who use any other investigational drug within one month prior to randomization.
•5.Known cases of Tuberculosis, HIV, Ischemic heart disease, Cancer.
•6.Known cases of Hypertension, Hyperacidity, Peptic ulcer, Duodenal ulcer.
•7.Pregnancy and Lactation.
•8.Other conditions, which in the opinion of investigators, makes the patient unsuitable for enrollment or could interfere with his/her participation in, and completion of the protocol.

发起方

Dr Prachi Patwari